Skip to search.
 TSX Up 0.60% TSX Ventures Up 1.02%

Novavax, Inc. (NVAX)

-NasdaqGS
12.06 Down 0.05(0.41%) Jul 31, 4:00PM EDT
Add to Portfolio
Prev Close:12.11
Open:12.13
Bid:11.09 x 100
Ask:13.55 x 300
1y Target Est:14.64
Beta:0.76
Earnings Date:Aug 4 - Aug 10 (Est.)
Day's Range:11.87 - 12.33
52wk Range:3.92 - 13.12
Volume:2,694,516
Avg Vol (3m):3,512,900
Market Cap:3.23B
P/E (ttm):N/A
EPS (ttm):-0.40
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
NVAXDown 0.41%3.23B
MRKUp 0.75%166.57B
NVSUp 0.55%250.57B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):98.10
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.41
Quarterly EPS Est (Jun-15) :-0.09
Mean Recommendation*:1.4
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Novavax, Inc., a clinical-stage vaccine company, focuses on discovering, developing, and commercializing recombinant nanoparticle vaccines and adjuvants. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback